BioSpace News Archive

Drug Development

ClearB Therapeutics Announces First Patient Dosed in a Phase 1b

ClearB Therapeutics, Inc. announced that the first patient has been dosed in the Phase 1b clinical study evaluating the therapeutic vaccine CLB-3000.

October 12, 2023
·
3 min read
Anaconda Biomed Announces Additional Granted Patents for its Innovative Thrombectomy Device for Ischemic Stroke Treatment

Anaconda Biomed S.L. has announced that the European Patent Office has granted the company a European patent for “A Device and a Thrombectomy Apparatus for Extraction of Thrombus from a Blood Vessel,” published as Patent No. EP3866708 B1 on September 27, 2023.

October 12, 2023
·
2 min read
Biotech Beach

BioAtla’s Jay M. Short, Ph.D., Selected for The Explorers Club Lowell Thomas Award

BioAtla, Inc. announced that Jay M. Short, Ph.D., Chairman, Chief Executive Officer and Cofounder, has been chosen by The Explorers Club as a recipient of this year’s Lowell Thomas Award.

October 12, 2023
·
7 min read
Pharm Country

Windtree to Present at the ThinkEquity Conference on October 19th in New York City

Windtree Therapeutics, Inc. today announced that Craig Fraser, President and Chief Executive Officer, will be presenting at the upcoming ThinkEquity Conference on Thursday, October 19, 2023 at 4:30pm ET.

October 12, 2023
·
2 min read
Business

Galectin Therapeutics Announces Nomination of Dr. Benjamin S. Carson, Sr. to Board of Directors

Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, announced today that Dr. Benjamin S. Carson, Sr. has been nominated to serve on the company’s board of directors.

October 12, 2023
·
7 min read
Ocean Biomedical and Virion Therapeutics Form Joint Venture Supporting Multi-National, First-In-Humans Clinical Chronic Hepatitis B Study: Now Enrolling, With Goal of a Functional Cure for a Disease Affecting 300+ Million Patients Worldwide

Ocean Biomedical, Inc. and Virion Therapeutics, LLC announced they have entered into a joint venture to accelerate and expand Virion’s clinical-stage program and pipeline, with the goal of finding cures for patients with cancer and chronic infectious diseases.

October 12, 2023
·
8 min read
Biotech Beach

Adagene Announces Poster Presentation on Optimal Dose Selection for Masked Anti-CTLA-4 SAFEbody® ADG126 at Upcoming Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting

Adagene Inc. today announced its poster presentation at the SITC 38th Annual Meeting taking place November 1-5, 2023 in San Diego.

October 12, 2023
·
3 min read
Business

Virion Therapeutics and Ocean Biomedical form joint venture supporting multi-national, first-in-humans clinical chronic hepatitis B study

Virion Therapeutics, LLC, and Ocean Biomedical, Inc. today announced they have entered into a joint venture to accelerate and expand Virion’s clinical-stage program and pipeline, with the goal of finding cures for patients with cancer and chronic infectious diseases.

October 12, 2023
·
8 min read
EndoSound and AdaptivEndo Partner to Revolutionize Endoscopy with Groundbreaking Technologies

EndoSound, a pioneer in endoscopic ultrasound technology (EUS), and AdaptivEndo, a leader in single-use endoscopy solutions, are proud to announce their letter of intent to collaborate on a new groundbreaking project that aims to transform the landscape of endoscopy.

October 12, 2023
·
3 min read
Bio NC

Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress

Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 30th Annual Congress.

October 12, 2023
·
1 min read